Craneware (CRW) Competitors

Craneware has a net margin of 10.63% compared to Instem's net margin of 5.50%. Craneware's return on equity of 6.65% beat Instem's return on equity.

Craneware currently has a consensus price target of GBX 2,222.75, suggesting a potential upside of 61.54%. Given Craneware's stronger consensus rating and higher possible upside, research analysts clearly believe Craneware is more favorable than Instem.

Craneware has higher revenue and earnings than Instem. Instem is trading at a lower price-to-earnings ratio than Craneware, indicating that it is currently the more affordable of the two stocks.

In the previous week, Craneware had 1 more articles in the media than Instem. MarketBeat recorded 1 mentions for Craneware and 0 mentions for Instem. Craneware's average media sentiment score of 0.00 equaled Instem'saverage media sentiment score.

33.6% of Craneware shares are held by institutional investors. Comparatively, 65.9% of Instem shares are held by institutional investors. 10.3% of Craneware shares are held by company insiders. Comparatively, 30.0% of Instem shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Craneware has a beta of 0.28, meaning that its share price is 72% less volatile than the broader market. Comparatively, Instem has a beta of 0.42, meaning that its share price is 58% less volatile than the broader market.

Craneware has higher revenue and earnings than Kooth. Craneware is trading at a lower price-to-earnings ratio than Kooth, indicating that it is currently the more affordable of the two stocks.

Craneware has a net margin of 10.63% compared to Kooth's net margin of 4.12%. Kooth's return on equity of 8.84% beat Craneware's return on equity.

In the previous week, Craneware had 1 more articles in the media than Kooth. MarketBeat recorded 1 mentions for Craneware and 0 mentions for Kooth. Kooth's average media sentiment score of 0.00 equaled Craneware'saverage media sentiment score.

Kooth has a beta of 1.286, meaning that its share price is 29% more volatile than the broader market. Comparatively, Craneware has a beta of 0.28, meaning that its share price is 72% less volatile than the broader market.

Kooth presently has a consensus price target of GBX 330, suggesting a potential upside of 78.38%. Craneware has a consensus price target of GBX 2,222.75, suggesting a potential upside of 61.54%. Given Kooth's higher probable upside, equities research analysts clearly believe Kooth is more favorable than Craneware.

21.0% of Kooth shares are held by institutional investors. Comparatively, 33.6% of Craneware shares are held by institutional investors. 30.4% of Kooth shares are held by company insiders. Comparatively, 10.3% of Craneware shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Craneware has a consensus target price of GBX 2,222.75, suggesting a potential upside of 61.54%. Given Craneware's stronger consensus rating and higher possible upside, analysts clearly believe Craneware is more favorable than Renalytix.

Craneware has higher revenue and earnings than Renalytix. Renalytix is trading at a lower price-to-earnings ratio than Craneware, indicating that it is currently the more affordable of the two stocks.

Renalytix has a beta of 1.81, meaning that its stock price is 81% more volatile than the broader market. Comparatively, Craneware has a beta of 0.28, meaning that its stock price is 72% less volatile than the broader market.

In the previous week, Renalytix and Renalytix both had 1 articles in the media. Renalytix's average media sentiment score of 0.49 beat Craneware's score of 0.00 indicating that Renalytix is being referred to more favorably in the media.

Craneware has a net margin of 10.63% compared to Renalytix's net margin of -506.25%. Renalytix's return on equity of 675.00% beat Craneware's return on equity.

14.0% of Renalytix shares are held by institutional investors. Comparatively, 33.6% of Craneware shares are held by institutional investors. 5.1% of Renalytix shares are held by company insiders. Comparatively, 10.3% of Craneware shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Craneware has higher revenue and earnings than Cambridge Cognition. Cambridge Cognition is trading at a lower price-to-earnings ratio than Craneware, indicating that it is currently the more affordable of the two stocks.

In the previous week, Craneware and Craneware both had 1 articles in the media. Cambridge Cognition's average media sentiment score of 0.75 beat Craneware's score of 0.00 indicating that Cambridge Cognition is being referred to more favorably in the news media.

Craneware has a beta of 0.28, indicating that its stock price is 72% less volatile than the broader market. Comparatively, Cambridge Cognition has a beta of 0.809, indicating that its stock price is 19% less volatile than the broader market.

Craneware has a net margin of 10.63% compared to Cambridge Cognition's net margin of -17.82%. Craneware's return on equity of 6.65% beat Cambridge Cognition's return on equity.

33.6% of Craneware shares are owned by institutional investors. Comparatively, 15.9% of Cambridge Cognition shares are owned by institutional investors. 10.3% of Craneware shares are owned by insiders. Comparatively, 3.2% of Cambridge Cognition shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Craneware currently has a consensus price target of GBX 2,222.75, indicating a potential upside of 61.54%. Cambridge Cognition has a consensus price target of GBX 56, indicating a potential upside of 82.41%. Given Cambridge Cognition's higher probable upside, analysts plainly believe Cambridge Cognition is more favorable than Craneware.